Saturday, March 12, 2011

Generics on the legal attack against Big Pharma's patents reports 
Big Pharma faces a host of well-known problems, most notably that its blockbuster drugs are coming off patent at the same time that its pipeline of new drugs has turned into a drip. But the leading pharmaceutical companies like Novartis (NVS), Merck (MRK, Fortune 500) and Bayer are also battling another costly headache -- legal challenges to their existing patents are increasing with the rapidity of a centrifuge.
The drug industry probably employs more high-powered lawyers than any other industry on the planet.  There is litigation all over the place (off-label, False Claims Act, Average Wholesale Price litigation, misbranding, personal injury, FDA compliance, patent litigation, and the list goes on). 

No comments:

Post a Comment